FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and aims at preventing and treating respiratory diseases, disorders or conditions. Implementing a method for preventing or treating the respiratory diseases, disorders or conditions involves administering a therapeutically effective amount of tetomilast and at least one beta2-adrenoreceptor agonist into the patient. According to the other embodiment, tetomilast and at least one beta2-adrenoreceptor agonist are administered together with at least one anti-inflammatory steroid. What is also presented is a pharmaceutical composition containing tetomilast and at least one beta2-adrenoreceptor agonist.
EFFECT: using the declared group of inventions provides the more effective prevention and treatments of respiratory diseases, disorders or conditions.
46 cl, 3 dwg, 6 tbl, 2 ex
